References
- BilezikianJPSilverbergSJNormocalcemic primary hyperparathyroidismArq Bras Endocrinol Metabol201054210610920485897
- EufrasinoCSHolandaNCPrazeresPABandeiraFEpidemiology of primary hyperparathyroidism and its nonclassical manifestations in the city of Recife, BrazilClin Med Insights Endocrinol Diabetes20136697424348080
- BandeiraFGrizLChavesNDiagnosis and management of primary hyperparathyroidism – a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and MetabolismArq Bras Endocrinol Metabol201357640642424030180
- AmaralLMBQueirozDCMarquesTFMendesMBandeiraFNormocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone?J Osteoporos2012201212835222545220
- Díaz-SotoGJuliánMTPuig-DomingoMNormocalcemic primary hyperparathyroidism: a newly emerging disease needing therapeutic interventionHormones201211439039623422761
- VignaliECetaniFChiavistelliSNormocalcemic primary hyperparathyroidism: a survey in a small village of Southern ItalyEndocr Connect20154317217826155986
- MarquesTFVasconcelosRDinizERêgoDGrizLBandeiraFNormocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat?Arq Bras Endocrinol Metabol201155531431721881813
- WalkerMDRubinMSilverbergSJNon-traditional manifestations of primary hyperparathyroidismJ Clin Densitom2013161404723374740
- KepezAHarmanciAHazirolanTEvaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patientsInt J Cardiovasc Imaging200925218719318784985
- WalkerMDFleischerJRundekTCarotid vascular abnormalities in primary hyperparathyroidismJ Clin Endocrinol Metab200994103849385619755478
- McClellandRLJorgensenNWBudoffM10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors. Derivation in the MESA (multi-ethnic study of atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) study and the DHS (Dallas Heart Study)J Am Coll Cardiol201566151643165326449133
- Tota-MaharajRBlahaMJBlanksteinRAssociation of coronary artery calcium and coronary heart disease events in young and elderly participants in the multi-ethnic study of atherosclerosis: a secondary analysis of a prospective, population-based cohortMayo Clin Proc201489101350135925236430
- SilverbergSJClarkeBLPeacockMCurrent issues in the presentation of asymptomatic primary hyperparathyroidism: Proceedings of the Fourth International WorkshopJ Clin Endocrinol Metab201499103580359425162667
- ManciaGFagardRNarkiewiczK2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20133171281135723817082
- ErsfeldDLRaoDSBodyJJAnalytical and clinical validation of the 25 OH vitamin D assay for the LIASON automated analyserClin Biochem2004371086787415369717
- ShabestariAACoronary artery calcium score: a reviewIran Red Crescent Med J20131512e1661624693399
- DetranoRGuerciADCarrJJCoronary calcium as a predictor of coronary events in four racial or ethnic groupsN Engl J Med2008358131336134518367736
- GreenlandPAlpertJSBellerGAAmerican College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Foundation/American Heart Association Task Force on practice guidelines adults: executive summary: a report of the American College of Cardiology 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in AsymptomaticCirculation20101222748276421098427
- DikicMTesicMMarkovicZPrognostic value of calcium score and coronary flow velocity reserve in asymptomatic diabetic patientsCardiovasc Ultrasound2015134126340922
- HagströmELundgrenERastadJHellmanPMetabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screeningEur J Endocrinol20061551333916793947
- ChenGXueYZhangQIs normocalcemic primary hyperparathyroidism harmful or harmless?J Clin Endocrinol Metab201510062420242425668199
- StoneNJRobinsonJGLichtensteinAH2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol20146325 pt B288924239923